Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

Narcotic use is rampant in workers compensation

Joseph Paduda
Meds
October 12, 2010
Share
Tweet
Share

Just in case you thought the problems with abuse of powerful prescription drugs have been overstated, here’s a wake-up call.

The CDC’s Director is taking this very seriously, saying: “Overdose with prescription drugs is one of the most serious and fastest-growing problems in this country.”

The problem is showing up in a doubling of emergency room admissions due to prescription drug abuse, driven primarily by oxycodone, methadone, and hydrocodone.

Narcotic use is rampant in workers compensation as well. Studies point to the frequent use of narcotic opioids for workers comp claimants, with the explosive growth in California particularly troubling.

One of the issues in worker’s comp is that unlike group, most Medicare Part D plans, and to a lesser extent Medicaid, claimant copays are nonexistent. There’s no financial skin in the game, as medications are free.

Another potential contributor is the potential street value of these drugs; while there isn’t conclusive documentation of the percentage of scripts that are diverted, the ‘sense of the industry’ is that diversion is not uncommon. Add to that the desire on the part of some states to reduce the work comp drug fee schedule to match Medicaid, and there’s no surprise use is exploding (if PBMs can’t afford to manage utilization, utilization isn’t managed).

Here’s what some of these drugs are reportedly worth on the street.

The estimated street value of one 40-milligram OxyContin pill is about $40; another report indicates an 80mg dose is going for $30 in the northeast.

Actiq runs about $25 a dose.

Duragesic patches range from $20-$75 depending on brand, location, and dosage.

So, narcotics are ripe for abuse, there’s a big – and very profitable – secondary market for them, and use is growing. That’s one side of the story.

The other is the inability of many legitimate pain sufferers to get adequate treatment. Research published by Oregon State University indicates “at least 30 percent of patients with moderate chronic pain and over 50 percent of those with severe chronic pain fail to achieve adequate pain relief.”

Some think the inability of those with chronic pain to get treatment through standard channels is a big component of the overall narcotic diversion issue.

What does this mean for you? Like so much else in health care, there are no clear problems or easy solutions. This is more evidence of the complexity of one small part of the challenge.

ADVERTISEMENT

Joseph Paduda is the principal of Health Strategy Associates, and blogs at Managed Care Matters.

Submit a guest post and be heard.

Prev

Making health care better, faster, and cheaper with collective innovations

October 12, 2010 Kevin 5
…
Next

HIV sufferers benefit from the FDA’s unapproved drugs initiative

October 13, 2010 Kevin 3
…

Tagged as: Medications

Post navigation

< Previous Post
Making health care better, faster, and cheaper with collective innovations
Next Post >
HIV sufferers benefit from the FDA’s unapproved drugs initiative

ADVERTISEMENT

More by Joseph Paduda

  • a desk with keyboard and ipad with the kevinmd logo

    Why health reform will not be repealed

    Joseph Paduda
  • a desk with keyboard and ipad with the kevinmd logo

    2 changes to cut Federal health care expenditures

    Joseph Paduda
  • a desk with keyboard and ipad with the kevinmd logo

    Controlling health care costs requires shared sacrifice

    Joseph Paduda

More in Meds

  • How CAR-NK cancer therapy could be safer than CAR-T

    Cliff Dominy, PhD
  • Psychedelic-assisted therapy: science, safety, and regulation

    Muhamad Aly Rifai, MD
  • The anticoagulant evidence controversy: a whistleblower’s perspective

    David K. Cundiff, MD
  • Is tramadol really ineffective and risky?

    John A. Bumpus, PhD
  • Unregulated botanical products: the hidden risks of convenience store supplements

    Muhamad Aly Rifai, MD
  • “The meds made me do it”: Unpacking the Nick Reiner tragedy

    Arthur Lazarus, MD, MBA
  • Most Popular

  • Past Week

    • Will AI replace primary care physicians?

      P. Dileep Kumar, MD, MBA | Tech
    • What is the minority tax in medicine?

      Tharini Nagarkar and Maranda C. Ward, EdD, MPH | Education
    • Why the U.S. health care system is failing patients and physicians

      John C. Hagan III, MD | Policy
    • Putting health back into insurance: the case for tobacco cessation

      Edward Anselm, MD | Policy
    • Why every physician needs a sabbatical (and how to take one)

      Christie Mulholland, MD | Physician
    • Retail health care vs. employer DPC: Preparing for 2026 policy shifts

      Dana Y. Lujan, MBA | Policy
  • Past 6 Months

    • Why patient trust in physicians is declining

      Mansi Kotwal, MD, MPH | Physician
    • How environmental justice and health disparities connect to climate change

      Kaitlynn Esemaya, Alexis Thompson, Annique McLune, and Anamaria Ancheta | Policy
    • Will AI replace primary care physicians?

      P. Dileep Kumar, MD, MBA | Tech
    • A physician father on the Dobbs decision and reproductive rights

      Travis Walker, MD, MPH | Physician
    • What is the minority tax in medicine?

      Tharini Nagarkar and Maranda C. Ward, EdD, MPH | Education
    • Is tramadol really ineffective and risky?

      John A. Bumpus, PhD | Meds
  • Recent Posts

    • Urological analysis of delayed cancer diagnoses in political figures [PODCAST]

      The Podcast by KevinMD | Podcast
    • The economics of prevention: Why an ounce is worth a pound

      Joshua Mirrer, MD | Conditions
    • Methamphetamine-induced lung injury: the hidden diagnosis in South Texas

      Shiv K. Goel, MD | Conditions
    • A 6-step framework for new health care leaders

      All Levels Leadership | Physician
    • The cost of ignoring pharmacist clinical judgment in health care

      Muhammad Abdullah Khan | Conditions
    • 10,000 steps before lunch: How a retired doctor models prevention

      Gerald Kuo | Conditions

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 5 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • Will AI replace primary care physicians?

      P. Dileep Kumar, MD, MBA | Tech
    • What is the minority tax in medicine?

      Tharini Nagarkar and Maranda C. Ward, EdD, MPH | Education
    • Why the U.S. health care system is failing patients and physicians

      John C. Hagan III, MD | Policy
    • Putting health back into insurance: the case for tobacco cessation

      Edward Anselm, MD | Policy
    • Why every physician needs a sabbatical (and how to take one)

      Christie Mulholland, MD | Physician
    • Retail health care vs. employer DPC: Preparing for 2026 policy shifts

      Dana Y. Lujan, MBA | Policy
  • Past 6 Months

    • Why patient trust in physicians is declining

      Mansi Kotwal, MD, MPH | Physician
    • How environmental justice and health disparities connect to climate change

      Kaitlynn Esemaya, Alexis Thompson, Annique McLune, and Anamaria Ancheta | Policy
    • Will AI replace primary care physicians?

      P. Dileep Kumar, MD, MBA | Tech
    • A physician father on the Dobbs decision and reproductive rights

      Travis Walker, MD, MPH | Physician
    • What is the minority tax in medicine?

      Tharini Nagarkar and Maranda C. Ward, EdD, MPH | Education
    • Is tramadol really ineffective and risky?

      John A. Bumpus, PhD | Meds
  • Recent Posts

    • Urological analysis of delayed cancer diagnoses in political figures [PODCAST]

      The Podcast by KevinMD | Podcast
    • The economics of prevention: Why an ounce is worth a pound

      Joshua Mirrer, MD | Conditions
    • Methamphetamine-induced lung injury: the hidden diagnosis in South Texas

      Shiv K. Goel, MD | Conditions
    • A 6-step framework for new health care leaders

      All Levels Leadership | Physician
    • The cost of ignoring pharmacist clinical judgment in health care

      Muhammad Abdullah Khan | Conditions
    • 10,000 steps before lunch: How a retired doctor models prevention

      Gerald Kuo | Conditions

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Narcotic use is rampant in workers compensation
5 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...